Net Cash Provided by (Used in) Operating Activities |
-36.1M |
USD |
-6571% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
396M |
USD |
|
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-204M |
USD |
-199% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
500M |
shares |
|
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
64.8M |
shares |
|
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
0 |
USD |
|
Q4 2023 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
147K |
USD |
|
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Valuation Allowance |
1.8M |
USD |
+15.4% |
Q4 2023 |
FY 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Gross |
1.8M |
USD |
+15.4% |
Q4 2023 |
FY 2023 |
Deferred Income Tax Expense (Benefit) |
0 |
USD |
|
Q4 2023 |
Q2 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Additional Paid in Capital |
0 |
USD |
|
Q4 2023 |
Q2 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Share-based Payment Arrangement, Expense |
22.9M |
USD |
|
Q2 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |